drugset / Trial / NCT00315016

Eplerenone, ACE Inhibition and Albuminuria

NCT00315016

Phase 2 Completed 30 enrolled Radboud University Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether eplerenone is more effective than doubling the dose of ACE inhibitor in reducing urinary protein (albumin) loss in diabetes mellitus

Timeline

Start
2007-01
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Eplerenone Unknown
Comparator Fosinopril Small molecule